Skip to main content

ORIGINAL RESEARCH article

Front. Cardiovasc. Med.
Sec. Atherosclerosis and Vascular Medicine
Volume 11 - 2024 | doi: 10.3389/fcvm.2024.1468566

Proposing new lipoprotein (a) cut off value for Kazakhstan: Pilot study

Provisionally accepted
Makhabbat Bekbossynova Makhabbat Bekbossynova Marat Aripov Marat Aripov Aknur Kali Aknur Kali *Tatyana Ivanova- Razumova Tatyana Ivanova- Razumova Dana Tleubayeva Dana Tleubayeva Ainur Tauekelova Ainur Tauekelova
  • University Medical Center Astana, Nur-sultan, Kazakhstan

The final, formatted version of the article will be published soon.

    for consideration as a "Frontiers in Cardiovascular Medicine". In Central Asia, including Kazakhstan, the prevalence of atherosclerotic cardiovascular disease has almost doubled over the last 40 years and to present day there are no studies devoted to determining Lp(a) thresholds for this population. In this regard, the aim of our study was to investigate the threshold value of Lp(a) in the adult population of Kazakhstan and to identify the relationship with the development of atherosclerotic cardiovascular disease. I believe that the content of this manuscript aligns with the scope and interests of your esteemed journal. We believe that this paper has the potential to make a meaningful contribution to the field of atherosclerosis. We are excited about the prospect of sharing our insights with the community and making a positive impact. I appreciate your consideration of my work and look forward to the possibility of seeing it published in Frontiers in Cardiovascular Medicine. Thank you for your time and attention to this submission.

    Keywords: Lipoprotein (a), Low-density lipoprotein cholesterol, Atherosclerotic cardiovascular diseases (ASCVD), aortic stenosis, ethnicity

    Received: 22 Jul 2024; Accepted: 03 Oct 2024.

    Copyright: © 2024 Bekbossynova, Aripov, Kali, Ivanova- Razumova, Tleubayeva and Tauekelova. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Aknur Kali, University Medical Center Astana, Nur-sultan, Kazakhstan

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.